Vigil Neuroscience Inc (VIGL)
US$ 1.790%
Price Chart
Key Statistics
Market Cap
$ 128.35M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
59.91K
52W High
$ 6.06
52W Low
$ 1.31
Dividend Yield
0.00%
Beta
1.95
Technicals
50-Day MA
1.9967
200-Day MA
2.7779
52 Week High
6.06
52 Week Low
1.312
About VIGL
Vigil Neuroscience, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel .
Employees
69
Headquarters
Watertown, MA
CEO
Dr. Ivana Magovcevic-Liebisch J.D., Ph.D.
Latest News
Why Vigil Neuroscience, Inc. (VIGL) is Skyrocketing So Far in 2025 - Yahoo Finance
2025-03-01 • Google News
Vigil Neuroscience, Inc. SEC 10-Q Report - TradingView
2 days ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg